Filing Details

Accession Number:
0001567619-18-000122
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-08 16:20:58
Reporting Period:
2018-08-06
Accepted Time:
2018-08-08 16:20:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561387 Health Insurance Innovations Inc. HIIQ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366008 Sheldon Wang C/o Health Insurance Innovations, Inc.
15438 N. Florida Ave., Suite 201
Tampa FL 33613
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2018-08-06 5,107 $12.13 38,782 No 4 M Direct
Class A Common Stock Acquisiton 2018-08-06 20,000 $4.95 58,782 No 4 M Direct
Class A Common Stock Acquisiton 2018-08-06 5,039 $6.77 63,821 No 4 M Direct
Class A Common Stock Disposition 2018-08-06 4,459 $43.75 59,362 No 4 D Direct
Class A Common Stock Disposition 2018-08-06 6,593 $43.33 52,769 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Appreciation Rights Disposition 2018-08-06 5,107 $0.00 5,107 $12.13
Class A Common Stock Stock Appreciation Rights Disposition 2018-08-06 5,039 $0.00 5,039 $6.77
Class A Common Stock Stock Appreciation Rights Disposition 2018-08-06 20,000 $0.00 20,000 $4.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-07-14 No 4 M Direct
0 2021-05-25 No 4 M Direct
0 2022-07-01 No 4 M Direct
Footnotes
  1. Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
  3. These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
  4. These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
  5. These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.